Keytruda Injection
Marketer
MSD Pharmaceuticals Pvt Ltd
Salt Composition
Pembrolizumab (100mg)
Overview Keytruda Injection
Pembrolizumab, administered intravenously, treats melanoma, non-small cell lung cancer, head and neck cancers, and cervical cancer. A healthcare professional infuses this medication; dosage and frequency are determined by your physician based on your condition and may vary. Adhere strictly to your doctor's instructions; incorrect usage or overdose can cause severe adverse reactions. Benefits may take weeks or months to appear; discontinue only under medical supervision. Common side effects include skin rash, tiredness, fever, nausea, and muscle aches. Serious infusion-related reactions, such as chills, shivering, itching, flushing, respiratory distress, and lightheadedness, necessitate prompt medical attention post-infusion. Inform your doctor of any pre-existing lung, liver, or kidney issues, or the use of infection-fighting medications, before starting treatment. Interactions with other drugs are possible; disclose all medications to your healthcare provider. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is crucial for both partners throughout treatment.
Uses of Keytruda Injection
Skin cancer (melanoma)|Lung cancer (non-small cell type)|Cancers of the head and neck|Uterine cervical cancer
Major Benefits of Keytruda Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Keytruda Injection:
- Rash
- Fatigue
- Fever
- Musculoskeletal (bone, muscle or joint) pain
- Stomach pain
- Nausea
- Itching
- Constipation
- Indigestion
- Diarrhea
- Decreased appetite
- Cough
How to use Keytruda Injection:
This medication will be administered by your physician or their qualified staff; self-medication is strictly prohibited.
How Keytruda Injection works:
Pembrolizumab, administered via injection, is a cancer therapy. Its mechanism of action in specific cancers involves bolstering the immune system to trigger T-cell responses that target malignant cells.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Keytruda injections may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Keytruda Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Consult your healthcare provider.
Breast feedingCONSULT YOUR DOCTOR
Breastfeeding while using Keytruda Injection is likely inadvisable. Available human data indicates potential drug transfer via breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Keytruda Injection on driving ability is unknown. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneyCAUTION
Pembrolizumab injection requires careful administration for individuals with impaired renal function. Dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should receive Keytruda Injection with careful monitoring. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Keytruda Injection :
NA
Facts to Know About Keytruda Injection
| Label | Value |
|---|---|
| Chemical Category | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Class | PD-1 Checkpoint Inhibitors |
3,018 People bought this recently
